Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brandt

Showing results (531-540 of 549) with videos related to

Pageof 55
Sort By:
Cardiovascular Research|January 30, 2016
THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- miceRemco A Haasdijk, Wijnand K Den Dekker, Caroline Cheng, et al.
Leukemia|November 1, 2016
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 28, 2015
The National Cancer Institute's Community Networks Program Initiative to Reduce Cancer Health Disparities: Outcomes and Lessons LearnedKathryn L Braun, Susan Stewart, Claudia Baquet, et al.
Leukemia|March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.
BMJ Open|December 11, 2019
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trialNadine Leonie de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen, et al.
The British Journal of Surgery|July 19, 2023
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastasesRuben A G van Eerden, Nadine L de Boer, Job P van Kooten, et al.
Circulation. Cardiovascular Genetics|March 22, 2017
Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin OrganizationSaskia Haitjema, Claartje A Meddens, Sander W van der Laan, et al.
BMC Cancer|April 27, 2021
Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trialM P Engbersen, C J V Rijsemus, J Nederend, et al.
Annals of Surgical Oncology|February 8, 2023
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II TrialC Bakkers, K P Rovers, A Rijken, et al.
BMJ Open|January 18, 2024
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trialVincent C J van de Vlasakker, Niels A D Guchelaar, Teun B M van den Heuvel, et al.
Pageof 55

Showing results (531-540 of 549) with videos related to

Sort By:
Pageof 55
Cardiovascular Research|January 30, 2016
THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- miceRemco A Haasdijk, Wijnand K Den Dekker, Caroline Cheng, et al.
Leukemia|November 1, 2016
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 28, 2015
The National Cancer Institute's Community Networks Program Initiative to Reduce Cancer Health Disparities: Outcomes and Lessons LearnedKathryn L Braun, Susan Stewart, Claudia Baquet, et al.
Leukemia|March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.
BMJ Open|December 11, 2019
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trialNadine Leonie de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen, et al.
The British Journal of Surgery|July 19, 2023
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastasesRuben A G van Eerden, Nadine L de Boer, Job P van Kooten, et al.
Circulation. Cardiovascular Genetics|March 22, 2017
Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin OrganizationSaskia Haitjema, Claartje A Meddens, Sander W van der Laan, et al.
BMC Cancer|April 27, 2021
Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trialM P Engbersen, C J V Rijsemus, J Nederend, et al.
Annals of Surgical Oncology|February 8, 2023
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II TrialC Bakkers, K P Rovers, A Rijken, et al.
BMJ Open|January 18, 2024
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trialVincent C J van de Vlasakker, Niels A D Guchelaar, Teun B M van den Heuvel, et al.
Pageof 55